Division of Rheumatology
USF Health

Investigator Initiated Grants (John D. Carter, M.D.)

  • Regional Grants in Aid (RGIA).
    “The Effect of a Low Carbohydrate, High Protein/Fat Diet on Bone Turnover.”
    Granting Agency: Procter & Gamble (Investigator Initiated Grant)
    Awarded August 2004.
    Completed May 2006; published 2006.
    Amount Awarded: $17,675.00
    Principal Investigator
  • Unrestricted Fellowship Educational Grant.
    “Training Fellows to Perform Clinical Research.”
    Granting Agency: Amgen.
    Awarded August 2004.
    Completed December 2004.
    Amount Awarded: $2500.00
    Principal Investigator
  • Investigator Initiated Grants Initiative.
    “Male Osteoporosis: Recognition & Treatment.”
    Granting Agency: Merck (Investigator Initiated Grant)
    Awarded October 2004.
    Project completed; manuscript in press
    Amount Awarded: $24,835.00
    Principal Investigator
  • NIH Exploratory/Developmental Research Grant Award (R21)
    “Combination Antimicrobial Therapy as a Treatment for Chlamydia-Induced Reactive Arthritis.”
    National Institutes of Health (National Institute of Musculoskeletal and Skin Diseases [NIAMS]).
    International Multi-Center Trial (4 Study Sites)
    Assignment Number: 1 R21 AR053646-01
    Start Date May 22, 2006
    Stop Date April, 2009
    Amount Awarded: $415,031.00
    Principal Investigator
  • “A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.”
    Sponsor: Genentech
    Amount: $501,125.00 (with the potential of $698,945.00 based on study extension)
    Status: Regulatory & Trial Initiation Phase
    Project: November, 2006 – January, 2010
    Target Enrollment: 50 patients
    Principal Investigator